Annexin Pharmaceuticals AB (publ) (Q910) Stock Price & News

All values in SEK	სექ. 2025	დეკ. 2025	მარ. 2026	ივნ. 2026
Revenue	-	-	-	-
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	7,05 მლნ.	8,00 მლნ.	7,92 მლნ.	8,48 მლნ.
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2,35 მლნ.	2,26 მლნ.	2,90 მლნ.	2,96 მლნ.
Operating expense	9,40 მლნ.	10,26 მლნ.	10,82 მლნ.	11,14 მლნ.
Total operating expenses	9,40 მლნ.	10,26 მლნ.	10,82 მლნ.	11,14 მლნ.
Operating income	-9,40 მლნ.	-10,26 მლნ.	-10,82 მლნ.	-11,14 მლნ.
Other non operating income	-	-	-	1,00 ათ.
EBT including unusual items	-9,90 მლნ.	-10,52 მლნ.	-10,52 მლნ.	-11,56 მლნ.
EBT excluding unusual items	-9,90 მლნ.	-10,52 მლნ.	-10,52 მლნ.	-11,56 მლნ.
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-	-	-	-288,00 ათ.
Net income	-9,90 მლნ.	-10,52 მლნ.	-10,52 მლნ.	-11,56 მლნ.
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	154,00 ათ.	231,00 ათ.	34,00 ათ.	-
Interest expense	-	-	-	-
Net interest expenses	154,00 ათ.	231,00 ათ.	34,00 ათ.	-
Depreciation and amortization charges	-	-	-	-
EBITDA	-9,35 მლნ.	-10,21 მლნ.	-10,77 მლნ.	-11,10 მლნ.
Gain or loss from assets sale	-	-	-	-

Ask anything